Results 161 to 170 of about 1,418,908 (242)

Analysis of the Dynamics of Clinical Parameters and Serum Angiogenic Factors in Systemic Sclerosis Patients Undergoing Tocilizumab Treatment. [PDF]

Exp Dermatol
Segawa Y, Takahashi T, Takahashi T, Oka K, Kambayashi Y, Takahashi T, Asano Y.   +6 more
europepmc   +1 more source

The Survival Rate of Hospitalized Lupus Patients With Overlap Disease. [PDF]

Cureus
Jaf JA, Faezi ST, Kasaeian A.
europepmc   +1 more source

Systemic scleroderma.

Minnesota medicine, 1966
openaire   +1 more source

Chronic graft versus host disease in upper limb: Calling upper limb rehabilitation specialists for improving outcomes in patients. [PDF]

Clin Hematol Int
Mohammed JA, Couthard C, AlGhamdi A, Ogbeivor C, Hashmi SK.   +4 more
europepmc   +1 more source

Editorial: Understanding scleroderma: symptoms, causes, treatment options, and advanced diagnostic techniques. [PDF]

Front Immunol
Ostojic P.
europepmc   +1 more source

Clinical significance of inflammation-coagulation-autoantibody triad in systemic sclerosis-associated interstitial lung disease: a retrospective study. [PDF]

Arthritis Res Ther
Guo R, Zhou X, Chen J, Gao J, Yang Y, Xu K.   +5 more
europepmc   +1 more source

Insight from convergent validity of assessment of systemic sclerosis-associated Raynaud phenomenon with nailfold capillaroscopy. [PDF]

Rheumatol Adv Pract
Madathanapalli KA, Memon A, Nadella M, Shelton K, Zamani M, Makhijani A, Williams A, Gunes I, Kujawski SE, Odell W, Perez S, Page N, Duran Camacho L, Van Horn C, Wilson FP, Domsic R, Yu L, Pauling JD, Hinchcliff M.   +18 more
europepmc   +1 more source

[On systemic scleroderma].

Terapevticheskii arkhiv, 1998
Ts, ISTAMONIVA, S I, RIABOV
openaire   +1 more source